Poor training - Avis employé Cytogenetic Technician NeoGenomics

3,0
1 avr. 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Good pay for the market

Inconvénients

Poor management and training, and management doesn’t seem to have planning. Safety concerns not taken seriously. Department has incredibly poor PTO system, don’t expect any for 8 months after hire.

Découvrez plus d’avis sur NeoGenomics

5,0
11 mars 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Growing business opportunities for many job seekers

Inconvénients

Ever changing approach on direction on projects

2,0
2 mars 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

The workforce wants to do the right thing. We take pride in knowing our services impact people's lives everyday.

Inconvénients

Constant turnover, lack of communication throughout - top to bottom. Leadership is struggling and not performing, Most of their attempts to improve growth have lost money. This is factual, not to be mistaken with statements from a disgruntled employee. An article published after the recent earnings release emphasized NEO's 5-year Return on Invested Capital is -10.5%, meaning management doesn't spend our capital wisely. This, along with heavy debt, minimal cash and returns at the bottom of the healthcare sector, should make you pause and do more research before jumping on board.

5
Voir les avis par: Utile|Évaluation|Date|Tout